Bromisoval

Bromisoval
Skeletal formula of bromisoval
Skeletal formula of bromisoval
Names
IUPAC name
(RS)-2-Bromo-N-carbamoyl-3-methylbutanamide
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
ECHA InfoCard 100.007.115
EC Number
  • 207-825-7
KEGG
MeSH Bromisovalum
UNII
  • InChI=1S/C6H11BrN2O2/c1-3(2)4(7)5(10)9-6(8)11/h3-4H,1-2H3,(H3,8,9,10,11) checkY
    Key: CMCCHHWTTBEZNM-UHFFFAOYSA-N checkY
  • CC(C)C(Br)C(=O)NC(N)=O
Properties
C6H11BrN2O2
Molar mass 223.070 g·mol−1
log P 1.057
Acidity (pKa) 10.536
Basicity (pKb) 3.461
Pharmacology
N05CM03 (WHO)
Oral
Related compounds
Related ureas
Carbromal
Related compounds
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Bromisoval (INN), commonly known as bromovalerylurea, is a hypnotic and sedative of the bromoureide group discovered by Knoll in 1907 and patented in 1909. It is marketed over the counter in Asia under various trade names (such as Brovarin), usually in combination with nonsteroidal anti-inflammatory drugs.

Bromisoval can be prepared by bromination of isovaleric acid by the Hell-Volhard-Zelinsky reaction followed by reaction with urea.